June 19, 2023

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked
peer-reviewed publication
proofread

Acetate controls endothelial-to-mesenchymal transition: Potential therapeutic target for reducing atherosclerosis

Graphical abstract. Credit: Cell Metabolism (2023). DOI: 10.1016/j.cmet.2023.05.010
× close
Graphical abstract. Credit: Cell Metabolism (2023). DOI: 10.1016/j.cmet.2023.05.010

In a new study, researchers including Yale School of Medicine's Michael Simons, MD, identify the molecular underpinnings of persistent endothelial-to-mesenchymal transition (EndMT), an important process related to vascular inflammation in diseases including pulmonary hypertension.

Researchers found atypical acetate production from triggered metabolic modulation of the endothelium activated TGF-β signaling, triggering a positive feedback loop and EndMT persistence.

The work identifies endothelial ACSS2 as a potential therapeutic target for reducing atherosclerosis. The study is published in the journal Cell Metabolism.

More information: Xiaolong Zhu et al, Acetate controls endothelial-to-mesenchymal transition, Cell Metabolism (2023). DOI: 10.1016/j.cmet.2023.05.010

Journal information: Cell Metabolism

Provided by Yale School of Medicine

Load comments (0)